 PRINCETON, N.J., July 27, 2021 GLOBE NEWSWIRE -- Certara NASDAQ: CERT, a global leader in biosimulation, today announced that Mubadala Investment Company Mubadala has made an approximately 250 million investment in Certara. The investment aligns with Mubadalas strategy of enabling innovation to address unmet clinical needs and drive cost efficiencies. 